Onkure Therapeutics Stock Net Income
| OKUR Stock | 2.90 0.05 1.75% |
Fundamental analysis of OnKure Therapeutics allows traders to better anticipate movements in OnKure Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Loss | -47.4 M | -49.8 M | |
| Net Loss | -47.4 M | -49.8 M | |
| Net Loss | (3.55) | (3.73) |
OnKure | Net Income | Build AI portfolio with OnKure Stock |
OnKure Therapeutics Company Net Income Analysis
OnKure Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current OnKure Therapeutics Net Income | (52.67 M) |
Most of OnKure Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OnKure Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OnKure Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for OnKure Therapeutics is extremely important. It helps to project a fair market value of OnKure Stock properly, considering its historical fundamentals such as Net Income. Since OnKure Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OnKure Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OnKure Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
OnKure Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, OnKure Therapeutics reported net income of (52.67 Million). This is 115.43% lower than that of the Biotechnology sector and 175.2% lower than that of the Health Care industry. The net income for all United States stocks is 109.23% higher than that of the company.
OnKure Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OnKure Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OnKure Therapeutics could also be used in its relative valuation, which is a method of valuing OnKure Therapeutics by comparing valuation metrics of similar companies.OnKure Therapeutics is currently under evaluation in net income category among its peers.
OnKure Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, OnKure Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to OnKure Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
OnKure Fundamentals
| Return On Equity | -2.07 | ||||
| Return On Asset | -0.97 | ||||
| Current Valuation | (30.35 M) | ||||
| Shares Outstanding | 12.86 M | ||||
| Shares Owned By Insiders | 1.72 % | ||||
| Shares Owned By Institutions | 86.38 % | ||||
| Number Of Shares Shorted | 51.99 K | ||||
| Price To Book | 0.59 X | ||||
| EBITDA | (51.71 M) | ||||
| Net Income | (52.67 M) | ||||
| Total Debt | 1.08 M | ||||
| Book Value Per Share | 4.90 X | ||||
| Cash Flow From Operations | (51.12 M) | ||||
| Short Ratio | 0.32 X | ||||
| Earnings Per Share | (4.68) X | ||||
| Target Price | 27.0 | ||||
| Number Of Employees | 46 | ||||
| Market Capitalization | 39.29 M | ||||
| Total Asset | 114.91 M | ||||
| Retained Earnings | (154.72 M) | ||||
| Working Capital | 102.47 M | ||||
| Net Asset | 114.91 M |
About OnKure Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OnKure Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OnKure Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OnKure Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with OnKure Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
The ability to find closely correlated positions to OnKure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics to buy it.
The correlation of OnKure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics' price analysis, check to measure OnKure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics is operating at the current time. Most of OnKure Therapeutics' value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics' price. Additionally, you may evaluate how the addition of OnKure Therapeutics to your portfolios can decrease your overall portfolio volatility.